Your browser doesn't support javascript.
loading
Effect of Cellular and Microenvironmental Multidrug Resistance on Tumor-Targeted Drug Delivery in Triple-Negative Breast cancer.
Tezcan, Okan; Elshafei, Asmaa Said; Benderski, Karina; Rama, Elena; Wagner, Maike; Moeckel, Diana; Pola, Robert; Pechar, Michal; Etrych, Tomas; von Stillfried, Saskia; Kiessling, Fabian; Weiskirchen, Ralf; Meurer, Steffen; Lammers, Twan.
Afiliação
  • Tezcan O; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Hospital RWTH Aachen, Aachen, Germany.; UT Brown Foundation Institute of Molecular Medicine, UTHealth Houston, Houston, TX, USA. Electronic address: okan.tezcan@uth.tmc.edu.
  • Elshafei AS; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Hospital RWTH Aachen, Aachen, Germany.
  • Benderski K; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Hospital RWTH Aachen, Aachen, Germany.
  • Rama E; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Hospital RWTH Aachen, Aachen, Germany.
  • Wagner M; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Hospital RWTH Aachen, Aachen, Germany.
  • Moeckel D; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Hospital RWTH Aachen, Aachen, Germany.
  • Pola R; Institute of Macromolecular Chemistry, Czech Academy of Science, Prague, Czech Republic.
  • Pechar M; Institute of Macromolecular Chemistry, Czech Academy of Science, Prague, Czech Republic.
  • Etrych T; Institute of Macromolecular Chemistry, Czech Academy of Science, Prague, Czech Republic.
  • von Stillfried S; Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University Hospital RWTH Aachen, Aachen, Germany.
  • Kiessling F; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Hospital RWTH Aachen, Aachen, Germany.
  • Weiskirchen R; Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), University Hospital RWTH Aachen, Aachen, Germany.
  • Meurer S; Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), University Hospital RWTH Aachen, Aachen, Germany.
  • Lammers T; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Hospital RWTH Aachen, Aachen, Germany.. Electronic address: tlammers@ukaachen.de.
J Control Release ; 354: 784-793, 2023 02.
Article em En | MEDLINE | ID: mdl-36599395

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias de Mama Triplo Negativas Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias de Mama Triplo Negativas Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article